ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

TEMP - Scientist, Lead Generation Biology at Neurocrine Biosciences - ApplyBlast

TEMP - Scientist, Lead Generation Biology

Neurocrine Biosciences

3 months ago

3.7 on Glassdoor

San Diego, CA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Neurocrine Biosciences seeks an experienced drug hunter to support and lead multiple drug discovery project teams within the in vitro pharmacology department. The role involves developing robust biochemical and cell-based assays, optimizing lead identification campaigns, and analyzing data to identify lead compounds for neurological and psychiatric disorders. Candidates will work with diverse assay technologies, automated equipment, and multidisciplinary teams to drive process efficiency and research quality.

Responsibilities

Develop and optimize biochemical and cell-based assays for drug discovery
Execute in vitro pharmacology assays to generate reproducible results
Analyze data to identify lead compounds and understand mechanisms of action
Document protocols in electronic laboratory notebooks and present findings
Collaborate with multidisciplinary teams to support lead optimization campaigns

Skills

Qualifications

BS/BA in Scientific FieldMS/MA in Scientific FieldPhD in Biology

About Neurocrine Biosciences

neurocrine.com

Headquarters

San Diego, California, United States

Company Size

1001-5000 employees

Founded

1992

View Profile

Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.